this study was designed to investigate the effect of soleus muscle kinetic control training on Gait and electromyographic activity of the calf muscle in patients with stroke

Stroke is a neurological condition characterized by a reduced blood supply to the brain tissue, resulting in paralysis of part or all of the body, limiting physical activity and social participation. Gait impairment accounts for the largest proportion of physical activity limitations in stroke patients and is characterized by muscle weakness, foot drop, spasticity, and foot deformity .Gait abnormalities following stroke are often disabling. Reduced ankle dorsiflexion, knee flexion, or hip flexion torques are often postulated causes of compromised toe clearing during the swing phase of gait. conversely, gait asymmetry and reduced walking speed has been attributed to weakness of the planter flexors.The kinetic control comprises balanced presentation of the movement choices with ideal interaction among the key components for the sensorimotor neuromuscular control that mediated by afferent sensory input, particularly the proprioceptive input, CNS integration, optimal motor co-ordination, and physiological stresses to assure functional dynamic stability and controlled mobility. forty patients with stroke will be assigned to two groups; one group will recieve kinetic control plus conventional therapy and control group will receive conventinoal therapy alone.

Inclusion Criteria:

• Ischemic or hemorrhagic stroke, as confirmed by CT and or MRI scan.
• Age of the patients between 45 to 60 years old.
• Ability to walk a minimum of 10 m with or without some physical assistance from a therapist (functional ambulation category more than 2).
• Demonstrate weakness of the foot muscles, measured by muscle function tests according Medical Research council scale more than 3.
• Muscle tone of the affected lower limb ranges from 1 to +1 according to modified Ashworth scale.

Exclusion Criteria:

• Unilateral neglect, hemianopia, or apraxia
• Having any other neurological disorder affecting their lower extremities e.g. MS, Parkinsonism, peripheral neuropathy.
• Patients with previous fractures in lower limb (Ankle or foot).
• Patients with musculoskeletal disorder such as severe arthritis, ankle surgery, leg length discrepancy or contractures of fixed deformity of ankle joint.
• Patients with visual, auditory impairment affecting their ability to complete tasks.
• Patients with cognitive impairments

opaque sealed envelope